KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

TherapeuticsMD (TXMD) Asset Utilization Ratio (2016 - 2025)

Historic Asset Utilization Ratio for TherapeuticsMD (TXMD) over the last 13 years, with Q3 2025 value amounting to 0.07.

  • TherapeuticsMD's Asset Utilization Ratio rose 8086.98% to 0.07 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.07, marking a year-over-year increase of 8086.98%. This contributed to the annual value of 0.04 for FY2024, which is 12028.77% up from last year.
  • Per TherapeuticsMD's latest filing, its Asset Utilization Ratio stood at 0.07 for Q3 2025, which was up 8086.98% from 0.07 recorded in Q2 2025.
  • In the past 5 years, TherapeuticsMD's Asset Utilization Ratio ranged from a high of 1.33 in Q3 2023 and a low of 0.03 during Q2 2024
  • Moreover, its 5-year median value for Asset Utilization Ratio was 0.32 (2022), whereas its average is 0.37.
  • Its Asset Utilization Ratio has fluctuated over the past 5 years, first surged by 83044.05% in 2023, then crashed by 9782.36% in 2024.
  • TherapeuticsMD's Asset Utilization Ratio (Quarter) stood at 0.46 in 2021, then soared by 35.95% to 0.62 in 2022, then tumbled by 95.19% to 0.03 in 2023, then surged by 49.69% to 0.04 in 2024, then soared by 61.24% to 0.07 in 2025.
  • Its Asset Utilization Ratio stands at 0.07 for Q3 2025, versus 0.07 for Q2 2025 and 0.05 for Q1 2025.